Inception Growth Acquisition LTD 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Inception Growth Acquisition Limited's Form 10-K details its ongoing efforts to complete a business combination, its delisting from Nasdaq, and multiple extensions of its deadline, currently set for May 13, 2026.
OTC.Pink
Inception Growth Acquisition Limited reports a net income for 2024 but faces challenges including Nasdaq delisting and a limited timeframe to complete a business combination.
OTC.Pink
Inception Growth Acquisition Limited has filed an amendment to its annual report to clarify certain footnote disclosures related to shareholder equity and subsequent events, including trust account extensions and promissory notes.
OTC.Pink
Inception Growth Acquisition Limited has filed an amendment to its annual report to restate its financial statements for the year ended December 31, 2023.
OTC.Pink
Inception Growth Acquisition Limited details its capital structure, redemption rights, and ongoing efforts to complete a business combination in its annual 10-K filing.